TriaGen Wealth Management LLC bought a new position in shares of Exelon Corporation (NASDAQ:EXC - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 13,949 shares of the company's stock, valued at approximately $643,000.
Several other institutional investors have also recently made changes to their positions in EXC. Providence Wealth Advisors LLC grew its position in shares of Exelon by 0.6% in the first quarter. Providence Wealth Advisors LLC now owns 39,342 shares of the company's stock valued at $1,802,000 after purchasing an additional 217 shares during the period. Hazlett Burt & Watson Inc. grew its position in shares of Exelon by 46.4% in the first quarter. Hazlett Burt & Watson Inc. now owns 694 shares of the company's stock valued at $32,000 after purchasing an additional 220 shares during the period. CWM LLC grew its position in shares of Exelon by 0.7% in the first quarter. CWM LLC now owns 33,775 shares of the company's stock valued at $1,556,000 after purchasing an additional 226 shares during the period. Catalyst Financial Partners LLC grew its position in shares of Exelon by 2.4% in the first quarter. Catalyst Financial Partners LLC now owns 9,761 shares of the company's stock valued at $450,000 after purchasing an additional 230 shares during the period. Finally, Centre Asset Management LLC grew its position in shares of Exelon by 3.2% in the first quarter. Centre Asset Management LLC now owns 7,584 shares of the company's stock valued at $349,000 after purchasing an additional 233 shares during the period. Hedge funds and other institutional investors own 80.92% of the company's stock.
Exelon Stock Performance
EXC stock traded up $0.14 on Wednesday, hitting $44.88. The company's stock had a trading volume of 5,922,786 shares, compared to its average volume of 7,359,840. The firm has a 50 day moving average of $43.68 and a two-hundred day moving average of $44.03. Exelon Corporation has a 1 year low of $35.94 and a 1 year high of $48.11. The stock has a market cap of $45.33 billion, a price-to-earnings ratio of 17.06, a price-to-earnings-growth ratio of 2.58 and a beta of 0.38. The company has a current ratio of 0.95, a quick ratio of 0.85 and a debt-to-equity ratio of 1.66.
Exelon (NASDAQ:EXC - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported $0.39 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.02. The company had revenue of $5.43 billion during the quarter, compared to the consensus estimate of $5.47 billion. Exelon had a net margin of 11.16% and a return on equity of 9.85%. Exelon's quarterly revenue was up 1.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.47 EPS. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. Equities analysts predict that Exelon Corporation will post 2.64 EPS for the current fiscal year.
Exelon Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Monday, August 11th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, August 11th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.6%. Exelon's dividend payout ratio is 60.84%.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on the stock. UBS Group reiterated a "neutral" rating and issued a $48.00 target price (up previously from $47.00) on shares of Exelon in a research report on Friday, July 11th. Morgan Stanley reduced their target price on shares of Exelon from $49.00 to $48.00 and set an "equal weight" rating on the stock in a research note on Thursday, May 22nd. Evercore ISI lifted their target price on shares of Exelon from $48.00 to $51.00 and gave the stock an "in-line" rating in a research note on Friday, May 2nd. KeyCorp reduced their target price on shares of Exelon from $39.00 to $37.00 and set an "underweight" rating on the stock in a research note on Wednesday, July 16th. Finally, Guggenheim boosted their price target on shares of Exelon from $47.00 to $50.00 and gave the company a "buy" rating in a research note on Friday, May 2nd. Four research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Exelon presently has an average rating of "Hold" and an average target price of $47.20.
Read Our Latest Report on Exelon
Exelon Company Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Further Reading

Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.